在第三阶段瘤学试验中,统计学意义上的生存衍生的脆弱性在第三阶段瘤学试验中具有统计意义
Alexander D Sherry1,2, Yufei Liu3, Pavlos Msaouel4,5
1Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. alexanderdsherry@gmail.com.
NPJ precision oncology
|July 24, 2025
概括
第三阶段瘤学试验通常依赖于统计学意义,但这项研究揭示了脆弱性. 少数患者重新分配可以改变试验结果,质疑癌症研究中优越性发现的稳定性.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验 临床试验
背景情况:
- 第三阶段瘤学试验通常使用P值值来定义优越性.
- 由于P值的连续性,因此在临床试验中对它们的解释产生了批评.
研究的目的:
- 在第三阶段瘤学试验中评估统计学意义的稳定性.
- 引入和评估生存推断脆弱性指数 (SIFI) 作为统计学意义稳定性的衡量标准.
主要方法:
- 从230个III期瘤学试验的患者级数据的重建.
- 估计每个试验的生存推断脆弱性指数 (SIFI).
- 分析P值,SIFI和终点类型 (总生存率与替代终点) 之间的关系.
主要成果:
- 中位数SIFI为8名患者,占试验入学人数中位数的1.4%.
- P值,但不包括对统计显著性的解释,与SIFI相关联.
- 总体生存终点与代用终点相比,表现出更大的脆弱性.
结论:
- 在III期瘤学试验中的统计学意义可能是脆弱的,轻微的患者重新分配可能会改变对优越性的解释.
- 这些发现凸显了需要更强大的方法来确定瘤学的治疗优越性.
- 当前的统计显著性值可能无法充分捕捉试验结果的真实可靠性.
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Comparing the Survival Analysis of Two or More Groups
289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Assumptions of Survival Analysis
198
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198
Survival Curves
322
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
322
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K


